ISSN:

Journal Home

Diabetology and Metabolic Syndrome Q1 Unclaimed

BioMed Central Ltd. United Kingdom

Unfortunately this journal has not been claimed yet. For this reason, some information may be unavailable.

Diabetology and Metabolic Syndrome is a journal indexed in SJR in Endocrinology, Diabetes and Metabolism and Internal Medicine with an H index of 62. It is an CC BY Journal with a Single blind Peer Review review system, and It has a price of 1562 €. The scope of the journal is focused on diabetes, metabolic syndrome. It has an SJR impact factor of 1,195 and it has a best quartile of Q1. It is published in English. It has an SJR impact factor of 1,195.

Type: Journal

Type of Copyright: CC BY

Languages: English

Open Access Policy: Open Access

Type of publications:

Publication frecuency: -

Categories: Endocrinology, Diabetes and Metabolism (Q1) Internal Medicine (Q1)

Price

1562 €

Inmediate OA

NPD

Embargoed OA

- €

Non OA

Metrics

1,195

SJR Impact factor

62

H Index

193

Total Docs (Last Year)

367

Total Docs (3 years)

9080

Total Refs

1943

Total Cites (3 years)

366

Citable Docs (3 years)

4.9

Cites/Doc (2 years)

47.05

Ref/Doc

Comments

No comments ... Be the first to comment!

Publication speed *

Review quality *

Edition and editorial team *

Institutional email or ORCID *

* The email or ORCID field is only to validate the authenticity of the comment, the identity will not be public. .

Other journals with similar parameters

The Lancet Diabetes and Endocrinology Q1
Nature Reviews Endocrinology Q1
Endocrine Reviews Q1
Nature Metabolism Q1
Diabetes Care Q1

Compare this journals

Aims and Scope

Diabetes Metabolic syndrome